Elsevier

JACC: Cardiovascular Imaging

Volume 9, Issue 11, November 2016, Pages 1338-1348
JACC: Cardiovascular Imaging

State-of-the-Art Paper
CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia

https://doi.org/10.1016/j.jcmg.2016.09.010Get rights and content
Under an Elsevier user license
open archive

Abstract

Cardiovascular magnetic resonance (CMR) has evolved from a pioneering research tool to an established noninvasive imaging method for detecting inducible myocardial perfusion deficits. In this consensus document, experts of different imaging techniques summarize the existing body of evidence regarding CMR perfusion as a viable complement to other established noninvasive tools for the assessment of perfusion and discuss the advantages and pitfalls of the technique. A rapid, standardized CMR perfusion protocol is described, which is safe, clinically feasible, and cost-effective for centers with contemporary magnetic resonance equipment. CMR perfusion can be recommended as a routine diagnostic tool to identify inducible myocardial ischemia.

Key Words

cardiac MRI
diagnosis
ischemic heart disease

Abbreviations and Acronyms

CAD
coronary artery disease
CMR
cardiovascular magnetic resonance
LV
left ventricle
SPECT
single-photon emission computed tomography
PET
positron emission tomography

Cited by (0)

This paper was funded by an unrestricted grant by Bayer Pharma AG. Drs. Hendel, Schulz-Menger, Zemmrich, and Nagel have received consultancy fees, attended advisory boards, and have held lectures for a number of pharmaceutical companies including Bayer HealthCare. Dr. Friedrich is a board member, advisor, and shareholder of and has received consultancy fees from Circle Cardiovascular Imaging Inc., a company that develops software for CMR image evaluation. Dr. Flamm has served as a consultant to Bayer HealthCare. Dr. Mahmarian has served on the Speakers Bureau of and as a consultant for Astellas. Dr. Nagel has received grant support from Siemens Healthcare, Bayer HealthCare, TomTec, CVI42, MEDIS, and Philips Healthcare.